Diabetes and Specialty Pharmacies

STAT+: Wegovy is among drugs set to be targeted in the next round of Medicare price negotiations, researchers say

STAT

SEPTEMBER 23, 2024

The GLP-1 drug Wegovy tops the list of medications expected to be included in the next round of Medicare price negotiations, according to a paper in the Journal of Managed Care & Specialty Pharmacy. Last month, Medicare officials unveiled prices for the first 10 drugs chosen for negotiation.

Specialty Pharmacies

Specialty Pharmacies Diabetes Drug Pricing

Amber Specialty Pharmacy Selected to Dispense TZIELD™ (teplizumab), a Monoclonal Antibody Treatment to Delay Onset of Stage 3 Type 1 Diabetes in Patients Ages 8 Years and Older with Stage 2 Type 1 Diabetes

Amber

NOVEMBER 21, 2022

21, 2022) – Amber Specialty Pharmacy announces that it will begin dispensing TZIELD (teplizumab), an anti-CD3 monoclonal antibody, to delay Stage 3 Type 1 Diabetes (T1D) in patients ages 8 years and older with Stage 2 T1D. Read more about the pharmacy’s infusion service offerings here. OMAHA, Neb.

Specialty Pharmacies

Specialty Pharmacies Diabetes

Orsini Specialty Pharmacy Selected by Provention Bio as a Limited Distribution Partner for TZIELD

Orsini Pharmacy

NOVEMBER 30, 2022

Orsini Specialty Pharmacy, a leading independent specialty pharmacy focused on rare diseases and gene therapies, has been selected by Provention Bio, Inc. as a specialty pharmacy for TZIELD ® (teplizumab).

Specialty Pharmacies

Specialty Pharmacies Diabetes

Rethinking Glucose Monitoring With AI and Nanomaterials

Pharma Marketing Network

JUNE 13, 2025

By Max Kopp Diabetes care is entering a new era—yet even in 2025, continuous glucose monitors (CGMs) remain out of reach for millions. Despite a decade of innovation, current CGMs often fail to meet the needs of everyday people with type 2 diabetes, particularly those in under-resourced or underserved communities.

Diabetes

Diabetes Specialty Pharmacies

Health System Specialty Pharmacies Impact Medication Adherence, Total Cost of Care

Pharmacy Times

APRIL 29, 2024

HSSPs improve medication adherence and reduce total health care costs by directly managing medications for complex chronic conditions like cancer, diabetes, COPD and CHF.

Specialty Pharmacies

Specialty Pharmacies Diabetes

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

NOVEMBER 1, 2022

A similar inflection point now faces the specialty pharmaceutical industry. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc. About the author.

HIPAA

HIPAA Insurance Coverage and Processing Specialty Pharmacies Communication

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

Not Your Typical MSL

The Nontraditional Pharmacist

SEPTEMBER 9, 2019

And so I did internships during school in managed care pharmacy, I did coming out of pharmacy school a residency a managed care pharmacy where you’re really rotating through learning about all sorts of different areas within the health plan. During the residency I got a lot of good experience there.

Specialty Pharmacies

Specialty Pharmacies Diabetes Labelling Hospitals

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

Pharmacy Times

JUNE 23, 2025

It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans. The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target.

Diabetes

Diabetes HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies

ADA 2025: Insights into Diabetes, Obesity, and Pharmacist's Role in Advancing Care

Pharmacy Times

JUNE 20, 2025

In an interview with Pharmacy Times ®, Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, remote monitoring program coordinator and endocrinology clinical pharmacy specialist at the Cleveland Clinic, shares insights about the upcoming American Diabetes Association 85th Scientific Sessions.

Diabetes

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

Pharmacy Times

JUNE 23, 2025

Ready-to-use glucagon has made a transformative impact for individuals with diabetes. Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurance coverage.

Diabetes

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management

Formularies, Formulary Strategies, and Vigilante Formulary Review

Ramblings of a pharmacist

DECEMBER 27, 2024

Formulary Strategies have several flavors, which generally include: covered or not covered, tiering, quantity limits, prior authorization requirements, step therapy requirements and pharmacy network restrictions (specialty pharmacy only/limited distribution).

Insurance Coverage and Processing

Insurance Coverage and Processing Specialty Pharmacies Documentation Hospitals

ADA 2025: Advancing CGM Adoption for Type 2 Diabetes Care

Pharmacy Times

JUNE 23, 2025

Kevin Sayer, CEO of Dexcom, discusses the key barriers to continuous glucose monitoring (CGM) adoption for type 2 diabetes (T2D) in an interview with Pharmacy Times® at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois. The 3 largest PBMs now cover CGM for anybody with diabetes.

Diabetes

Diabetes Pharmacy Technician Compounding Pharmacies Compounding

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

JULY 2, 2024

Similarly, long-acting insulin analogs provide more stable blood sugar control and reduce the number of daily injections needed for diabetes patients. Pharmacy benefit managers: transparency, accountability, and impact on patient care. Journal of Managed Care & Specialty Pharmacy, 27(7), 903-907. Casalino, L.,

Drug Pricing

Drug Pricing Insurance Coverage and Processing Labelling HIPAA

ADA 2025: Bridging Gaps in Diabetes Management and Patient Care

Pharmacy Times

JUNE 22, 2025

He emphasizes the importance of staying updated on medical advancements through state pharmacy associations, digital health platforms, and engaging with students and residents. Pharmacy Times: What aspects of the ADA 2025 Scientific Sessions do you think will be most relevant to patients managing diabetes in a community pharmacy setting?

Diabetes

Diabetes Pharmacy Technician Compounding Pharmacies Compounding

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

Pharmacy Times

JUNE 26, 2025

SHOW MORE A groundbreaking trial shows zimislecel significantly reduces insulin dependence in type 1 diabetes patients, offering hope for a functional cure. 1,2 Image credit: Davizro Photography | stock.adobe.com Zimislecel works by restoring the pancreas’ ability to produce insulin and helping individuals regulate blood sugar levels.

Diabetes

Diabetes Pharmacy Technician Compounding Pharmacies Pharmacy Management

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

Pharmacy Times

JUNE 17, 2025

SHOW MORE New research reveals a significant link between type 2 diabetes, obesity, and fatty liver disease. Emerging study findings from investigators at Linköping University discovered that 6 out of 10 individuals with type 2 diabetes (T2D) had fatty liver.

Diabetes

Diabetes Pharmacy Technician Compounding Pharmacies Hospitals

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

JANUARY 27, 2025

The NHC recognizes that Medicare already covers AOMs for patients who are overweight and have comorbid conditions such as diabetes or cardiovascular disease. However, we urge CMS to consider broadening eligibility criteria to include individuals who are overweight but have not yet developed these conditions. 14 National Health Council.

Insurance Coverage and Processing

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

STAT+: Wegovy is among drugs set to be targeted in the next round of Medicare price negotiations, researchers say

Amber Specialty Pharmacy Selected to Dispense TZIELD™ (teplizumab), a Monoclonal Antibody Treatment to Delay Onset of Stage 3 Type 1 Diabetes in Patients Ages 8 Years and Older with Stage 2 Type 1 Diabetes

Trending Sources

Orsini Specialty Pharmacy Selected by Provention Bio as a Limited Distribution Partner for TZIELD

Rethinking Glucose Monitoring With AI and Nanomaterials

Health System Specialty Pharmacies Impact Medication Adherence, Total Cost of Care

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Not Your Typical MSL

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

ADA 2025: Insights into Diabetes, Obesity, and Pharmacist's Role in Advancing Care

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

Formularies, Formulary Strategies, and Vigilante Formulary Review

ADA 2025: Advancing CGM Adoption for Type 2 Diabetes Care

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

ADA 2025: Bridging Gaps in Diabetes Management and Patient Care

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

ADA 2025: CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

ADA 2025: Technology, Treatment, and Transformation in Diabetes Management

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

ADA 2025: Empowering Type 2 Diabetes Patients Through Advanced Glucose Monitoring

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Advancing Pericarditis Care: The Evolving Role of IL-1 Inhibition and Pharmacist-Cardiologist Collaboration

Research Finds Low-Energy Total Diet Replacement Does Not Increase Eating Disorder Symptoms in Individuals with Overweight or Obesity

ADA 2025: Breaking Barriers in Glucagon Prescription

McKesson Corporation Completes Acquisition of Core Ventures

Drawn to Understand: How Culturally Tailored Education Empowers Patients With Type 1 Diabetes

Research Suggests Vitamin D Deficiency Is a Risk Factor for Autism

Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations

Spring 2025 Quiz: Test Your Pharmacy Knowledge!

Nitisinone Becomes First and Only FDA-Approved Treatment for HGA in Adults With AKU

OTC Case Studies: Summer Skin Care

Stay Connected